Intravoxel incoherent motion diffusion-weighted imaging in nonalcoholic fatty liver disease: A 3.0-T MR study

Radiology

Volumn 265, Issue 1, 2012, Pages 96-103

  Guiu, Boris ^a,b   Petit, Jean Michel ^a,b   Capitan, Violaine ^b   Aho, Serge ^a,b   Masson, David ^a,b   Lefevre, Pierre Henri ^b   Favelier, Sylvain ^b   Loffroy, Romaric ^b   Vergès, Bruno ^a,b   Hillon, Patrick ^a,b   Krausé, Denis ^b   Cercueil, Jean Pierre ^a,b  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; FATTY LIVER; FEMALE; HUMAN; IMAGE ANALYSIS; INTRAVOXEL INCOHERENT MOTION; LIVER PERFUSION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PERFUSION FRACTION; PERFUSION RELATED DIFFUSION; PHYSICAL PARAMETERS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PURE MOLECULAR DIFFUSION; RADIOLOGICAL PARAMETERS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; DIFFUSION MAGNETIC RESONANCE IMAGING; FATTY LIVER; FEMALE; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 84866611123     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12112478     Document Type: Article

References (39)

1. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168(2):497-505.
2. Guiu B, Cercueil JP. Liver diffusion-weighted MR imaging: the tower of Babel? Eur Radiol 2011;21(3):463-467.
3. Luciani A, Vignaud A, Cavet M, et al. Liver cirrhosis: intravoxel incoherent motion MR imaging - pilot study. Radiology 2008;249(3):891-899.
4. Patel J, Sigmund EE, Rusinek H, Oei M, Babb JS, Taouli B. Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging 2010;31(3):589-600.
5. Anderson SW, Jara H, Ozonoff A, O'Brien M, Hamilton JA, Soto JA. Effect of disease progression on liver apparent diffusion coefficient and T2 values in a murine model of hepatic fibrosis at 11.7 Tesla MRI. J Magn Reson Imaging 2012;35(1):140-146.
6. Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 2010;5:145-171.
7. Anderson SW, Soto JA, Milch HN, et al. Effect of disease progression on liver apparent diffusion coefficient values in a murine model of NASH at 11.7 Tesla MRI. J Magn Reson Imaging 2011;33(4):882-888.
8. Sato N, Eguchi H, Inoue A, Matsumura T, Kawano S, Kamada T. Hepatic microcirculation in Zucker fatty rats. Adv Exp Med Biol 1986;200:477-483.
9. Teramoto K, Bowers JL, Kruskal JB, Clouse ME. Hepatic microcirculatory changes after reperfusion in fatty and normal liver transplantation in the rat. Transplantation 1993;56(5):1076-1082. (Pubitemid 23348677)
10. Rijzewijk LJ, van der Meer RW, Lubberink M, et al. Liver fat content in type 2 diabetes: relationship with hepatic perfusion and substrate metabolism. Diabetes 2010;59(11):2747-2754.
11. Johnson NA, Walton DW, Sachinwalla T, et al. Noninvasive assessment of hepatic lipid composition: advancing understanding and management of fatty liver disorders. Hepatology 2008;47(5):1513-1523. (Pubitemid 351702735)
12. Perseghin G, Lattuada G, De Cobelli F, et al. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver. Hepatology 2008;47(1):51-58. (Pubitemid 351171041)
13. Targher G, Bertolini L, Rodella S, et al. Non-alcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 2007;30(8):2119-2121. (Pubitemid 47219432)
14. Guiu B, Petit JM, Loffroy R, et al. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology 2009;250(1):95-102.
15. Jacqueminet S, Lebray P, Morra R, et al. Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes. Clin Gastroenterol Hepatol 2008;6(7):828-831.
16. Poynard T, Morra R, Halfon P, et al. Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol 2007;7:40.
17. Ratziu V, Massard J, Charlotte F, et al. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol 2006;6:6.
18. 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 2006;240(2):318-332.
19. Naressi A, Couturier C, Devos JM, et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA 2001;12(2-3):141-152. (Pubitemid 32510133)
20. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005;288(2):E462-E468. (Pubitemid 40110657)
21. Kotronen A, Peltonen M, Hakkarainen A, et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 2009;137(3):865-872.
22. Le Bihan D. The 'wet mind': water and functional neuroimaging. Phys Med Biol 2007;52(7):R57-R90. (Pubitemid 46646365)
23. Lemke A, Laun FB, Simon D, Stieltjes B, Schad LR. An in vivo verification of the intravoxel incoherent motion effect in diffusion-weighted imaging of the abdomen. Magn Reson Med 2010;64(6):1580-1585.
24. Lewin M, Fartoux L, Vignaud A, Arrivé L, Menu Y, Rosmorduc O. The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study. Eur Radiol 2011;21(2):281-290.
25. Moteki T, Horikoshi H. Evaluation of hepatic lesions and hepatic parenchyma using diffusion-weighted echo-planar MR with three values of gradient b-factor. J Magn Reson Imaging 2006;24(3):637-645. (Pubitemid 44320568)
26. Moteki T, Horikoshi H. Evaluation of non-cirrhotic hepatic parenchyma with and without significant portal vein stenosis using diffusion-weighted echo-planar MR on the basis of multiple-perfusion-components theory. Magn Reson Imaging 2011;29(1):64-73.
27. Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 1999;210(3):617-623. (Pubitemid 29124018)
28. Balci A, Karazincir S, Sumbas H, Oter Y, Egilmez E, Inandi T. Effects of diffuse fatty infiltration of the liver on portal vein flow hemodynamics. J Clin Ultrasound 2008;36(3):134-140. (Pubitemid 351441222)
29. Seifalian AM, Chidambaram V, Rolles K, Davidson BR. In vivo demonstration of impaired microcirculation in steatotic human liver grafts. Liver Transpl Surg 1998;4(1):71-77. (Pubitemid 28053314)
30. McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrell GC. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. Hepatology 2004;40(2):386-393. (Pubitemid 39062856)
31. Brock RW, Dorman RB. Obesity, insulin resistance and hepatic perfusion. Microcirculation 2007;14(4-5):339-347. (Pubitemid 47050026)
32. Jiang ZY, Lin YW, Clemont A, et al. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 1999;104(4):447-457. (Pubitemid 29534329)
33. Stanisz GJ, Odrobina EE, Pun J, et al. T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med 2005;54(3):507-512.
34. Hamilton G, Middleton MS, Bydder M, et al. Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification. J Magn Reson Imaging 2009;30(1):145-152.
35. Guiu B, Petit JM, Loffroy R, et al. Liver methylene fraction by dual- and triple-echo gradient-echo imaging at 3.0T: correlation with proton MR spectroscopy and estimation of robustness after SPIO administration. J Magn Reson Imaging 2011;33(1):119-127.
36. Guiu B, Loffroy R, Cercueil JP, Krause D. Multiecho MR imaging and proton MR spectroscopy for liver fat quantification (letter). Radiology 2008;249(3):1081.
37. Allard JP, Aghdassi E, Mohammed S, et al. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. J Hepatol 2008;48(2):300-307.
38. Puri P, Baillie RA, Wiest MM, et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007;46(4):1081-1090. (Pubitemid 350144772)
39. Chalasani N. Nonalcoholic fatty liver disease liver fat score and fat equation to predict and quantitate hepatic steatosis: promising but not prime time! Gastroenterology 2009;137(3):772-775.